Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

Add To Watchlist

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Core business sold.

View:

Post by DryBones on Nov 04, 2019 1:50pm

Core business sold.

Yep, One of its few producing assets. Now there are even less tangible assets. And don't tell me Ryplazim is a tangible asset. It is nothing until the FDA approves it, and for some reason they won't So even Ryplazim is just a flying-turd.

159

Comment

Comment by Thesweetheart on Nov 05, 2019 5:10pm

were you Reddy for the 2nd stage of final act? Zero soon!

Comment

Comment by realstocky on Nov 05, 2019 5:56pm

This post has been removed in accordance with Community Policy

Comment by stockman6767 on Nov 05, 2019 7:44pm

Realstocky, on what basis do you produce your nonsensical result. Show us your brilliant analysis of the P&L data to us, why don't you - otherwise your baseless assertions are totally useless!

Comment